DEVELOPMENT, LICENCE AND COLLABORATION AGREEMENTDevelopment, License and Collaboration Agreement • May 10th, 2004 • Viragen Inc • Biological products, (no disgnostic substances)
AMENDMENT 2 DEVELOPMENT, LICENSE AND COLLABORATION AGREEMENT BETWEEN ROSLIN INSTITUTE (EDINBURGH), VIRAGENICS AND VIRAGEN, INC. (the Agreement)Development, License and Collaboration Agreement • July 31st, 2006 • Viragen Inc • Biological products, (no disgnostic substances)
This Amendment 2 to the Agreement is hereby mutually agreed upon by the Parties hereto, as evidenced by authorised signatures below, and is effective from the last date of signature hereof. Unless the context herein otherwise requires, the words and expressions defined in the Agreement and/or in Amendment 1, shall have the same meaning in this Amendment 2.
ContractDevelopment, License and Collaboration Agreement • July 31st, 2006 • Viragen Inc • Biological products, (no disgnostic substances)
Information marked below by a [ ] has been omitted pursuant to a request for confidential treatment filed separately with the Commission.
